Amylyx Pharmaceuticals
AMLX
AMLX
147 hedge funds and large institutions have $1.51B invested in Amylyx Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 60 increasing their positions, 36 reducing their positions, and 24 closing their positions.
Holders
147
Holders Change
+14
Holders Change %
+10.53%
% of All Funds
2.35%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
38
Increased
60
Reduced
36
Closed
24
Calls
$56.4M
Puts
$31.4M
Net Calls
+$25M
Net Calls Change
+$35.6M
Top Buyers
1 |
![]()
1
Marshall Wace
London,
United Kingdom
|
$33.4M |
2 |
APM
2
Avidity Partners Management
Dallas,
Texas
|
$26.4M |
3 |
O
3
OrbiMed
New York
|
$23.9M |
4 |
4
D.E. Shaw & Co
New York
|
$59.3M |
5 |
GPP
5
Great Point Partners
Greenwich,
Connecticut
|
$23M |